title: Epidermal insulin resistance as a therapeutic target in acanthosis nigricans?
authors: Department of Dermatology, University Hospital, Theodor-Stern-Kai 7, DE-60590 Frankfurt/Main, Germany.
authors: Bartosz
authors: B
authors: Malisiewicz
authors: Sandra
authors: S
authors: Boehncke
authors: Victoria
authors: V
authors: Lang
authors: Wolf-Henning
authors: WH
authors: Boehncke
authors: Claudia
authors: C
authors: Buerger
mesh_terms: D000052:Acanthosis Nigricans / Q000150:complications / Q000188:drug therapy*; D000328:Adult; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy; D004817:Epidermis / Q000502:physiology; D005260:Female; D052216:Glucagon-Like Peptide 1 / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007333:Insulin Resistance / Q000502:physiology; D000069450:Liraglutide
chemical_list: D007004:Hypoglycemic Agents; D000069450:Liraglutide; D052216:Glucagon-Like Peptide 1